1. Home
  2. GERN vs AMPL Comparison

GERN vs AMPL Comparison

Compare GERN & AMPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GERN
  • AMPL
  • Stock Information
  • Founded
  • GERN 1990
  • AMPL 2012
  • Country
  • GERN United States
  • AMPL United States
  • Employees
  • GERN N/A
  • AMPL N/A
  • Industry
  • GERN Biotechnology: Pharmaceutical Preparations
  • AMPL EDP Services
  • Sector
  • GERN Health Care
  • AMPL Technology
  • Exchange
  • GERN Nasdaq
  • AMPL Nasdaq
  • Market Cap
  • GERN 1.5B
  • AMPL 1.5B
  • IPO Year
  • GERN 1996
  • AMPL 2021
  • Fundamental
  • Price
  • GERN $2.57
  • AMPL $13.42
  • Analyst Decision
  • GERN Strong Buy
  • AMPL Buy
  • Analyst Count
  • GERN 11
  • AMPL 8
  • Target Price
  • GERN $6.82
  • AMPL $14.86
  • AVG Volume (30 Days)
  • GERN 12.4M
  • AMPL 900.8K
  • Earning Date
  • GERN 02-26-2025
  • AMPL 02-19-2025
  • Dividend Yield
  • GERN N/A
  • AMPL N/A
  • EPS Growth
  • GERN N/A
  • AMPL N/A
  • EPS
  • GERN N/A
  • AMPL N/A
  • Revenue
  • GERN $29,480,000.00
  • AMPL $299,272,000.00
  • Revenue This Year
  • GERN $31,918.56
  • AMPL $9.96
  • Revenue Next Year
  • GERN $289.41
  • AMPL $7.62
  • P/E Ratio
  • GERN N/A
  • AMPL N/A
  • Revenue Growth
  • GERN 9199.68
  • AMPL 8.32
  • 52 Week Low
  • GERN $1.64
  • AMPL $7.37
  • 52 Week High
  • GERN $5.34
  • AMPL $14.88
  • Technical
  • Relative Strength Index (RSI)
  • GERN 31.98
  • AMPL 60.99
  • Support Level
  • GERN $2.49
  • AMPL $11.73
  • Resistance Level
  • GERN $2.84
  • AMPL $14.88
  • Average True Range (ATR)
  • GERN 0.15
  • AMPL 0.62
  • MACD
  • GERN -0.01
  • AMPL 0.09
  • Stochastic Oscillator
  • GERN 13.33
  • AMPL 54.00

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

About AMPL Amplitude Inc.

Amplitude Inc is a Software company that provides a Digital Analytics Platform that helps companies analyze their customer behavior within digital products. The Company delivers its application over the Internet as a subscription service using a software-as-a-service (SaaS) model and also it offers customer support related to initial implementation setup, ongoing support services, and application training. The company generates revenue primarily through selling subscriptions to the platform. The company derives a majority of its revenue from the United States.

Share on Social Networks: